HAE Haemonetics Company Year-over-year net earnings per share growth for the last 12 months
The quarterly EPS growth rate in the GURU.Markets system is available via a chart, where 22.60 represents the most recent level, allowing users to filter out noise from actual profit dynamics. The defensive nature of the Haemonetics Corporation (HAE) business relies on the constant demand for plasma. Leadership in blood processing ensures high-quality FCF. The expansion of hospital networks effectively scales the sales of high-margin consumables.
Comprehensive metric breakdowns and analytics for Haemonetics Company (HAE)
- share price and expert price forecast:
- market capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital Haemonetics Corporation|HAE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Haemonetics Corporation|HAE - Company Total Debt Obligations|Debts to Book Capitalization Haemonetics Corp.|HAE - Company Long-Term Liabilities|Company Short-Term Debts Haemonetics|Quick Liquidity haemonetics.com
- earnings and market multiples details:
HAE - Company Net Income|Future Profit Haemonetics Corporation|HAE - Company Value to Net Income|Forward P/E Multiple Haemonetics Corp.|HAE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Haemonetics Corp.|HAE - Operating profit before depreciation charges|Net earnings per share for the last 12 months Haemonetics|HAE - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth haemonetics.com|HAE - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Haemonetics Corporation
- revenue and sales proceeds data:
Analysis of all company metrics:Haemonetics - HAE
Defensive assets are selected based on the stability of their cash flows. Haemonetics Corporation (HAE) confirms this status through high-precision logistics of consumables for blood transfusion centers. An analysis of quarterly EPS growth measures the percentage change in net income per share relative to the previous period. This indicator reveals the actual efficiency of operational capital management. A positive trend confirms the business's resilience to market volatility.
Main competitors
DXCM: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Penumbra Inc|Year-over-year net earnings per share growth for the last 12 months NOVT|INSP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months PROCEPT BioRobotics (PRCT)|Year-over-year net earnings per share growth for the last 12 months conmed.com CNMD|Quarterly EPS earnings growth PLSE (Pulse Biosciences)|InMode Ltd (INMD) - Earnings per share growth in annualized terms for the last twelve months|Picard Medical Inc. - Quarterly EPS earnings growth|SRDX (Surmodics Inc.) - Year-over-year earnings per share growth for the last 12 months|SENS: Quarterly EPS earnings growth|NPCE - Year-over-year net earnings per share change for the last twelve months|TCMD (Tactile Systems Technology, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months SANUWAVE Health (SNWV)|Quarterly EPS earnings growth OM|Quarterly EPS earnings growth smartvest.com (ELMD)|Year-over-year earnings per share growth for the last twelve months LENSAR, Inc. LNSR|avitamedical.com - Year-over-year earnings per share growth for the last twelve months|PROF: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months BDMD (Baird Medical Investment)|EDAP: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Apyx Medical Corporation (APYX)|Year-over-year earnings per share growth for the last twelve months IceCure Medical Ltd.|LUNG - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months TELA (TELA Bio, Inc.)|Quarterly EPS earnings growth cytosorbents.com (CTSO)|Quarterly EPS earnings growth SRTS (Sensus Healthcare Corp)|Year-over-year net earnings per share change for the last twelve months Zynex Corp (ZYXI)|ECOR - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months RBOT|inspira-technologies.com (IINN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months SeaStar Medical Holding Corporation|IRIX (IRIDEX Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Intelligent Bio INBS|Year-over-year earnings per share growth for the last twelve months Beyond Air, Inc. (XAIR)|profusa.com - Year-over-year earnings per share growth for the last 12 months|STRATA Skin Sciences, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months VERO (Venus Concept Corporation)|NUWE: Quarterly EPS earnings growth|aethlonmedical.com (AEMD) - Quarterly EPS earnings growth|ASXC (Asensus Surgical Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Avinger Inc. AVGR|Year-over-year earnings per share growth for the last twelve months Biosig Technologies (BSGM)|Year-over-year net earnings per share growth for the last 12 months Cutera Inc CUTR|Year-over-year earnings per share growth for the last twelve months Know Labs, Inc. KNW|inarimedical.com (NARI) - Earnings per share growth in annualized terms for the last twelve months|NVRO - Year-over-year earnings per share growth for the last twelve months|RSLS (ReShape Lifesciences) - Year-over-year earnings per share growth for the last 12 months|SILK: Quarterly EPS earnings growth
